Genetic Disorders

 

The NLM have been donated 10,000 protective masks to the Civil Protection

Beta Globin Plus Test, code AC104

Code: AC104

KIT Name: Beta Globin Plus Test

Description: The device provides reagents for the identification of the α-Globin Gene Triplications (anti 3.7) and 14 mutations/deletions of beta-globin gene (HBB), through the amplification of the target sequences, reverse-hybridization and color development. Beta thalassemias are an heterogeneous group of hereditary autosomal recessive blood disorders resulting in variable phenotypes. They are caused by a reduced (beta +) or absent (beta 0) synthesis of the beta-globin chains of the hemoglobin tetramer, due to alterations in beta-globin gene (HBB) on chromosome 11. Concerning the clinical and haematological features, β-thalassemias are classified according to severity: thalassemia minor (carrier of beta thalassemia), thalassemia intermedia and thalassemia major. Forms of HPFH may be caused by large deletions within the β-globin cluster or point mutations in the proximal or distant promoter regions of the fetal globin genes.

Extraction: AA1001, AA340

Detection: RDB on Strip

Test: 20

Copyright MAXXmarketing GmbH

 

Nuclear Laser Medicine srl
Viale delle Industrie, 3 - 20049
Settala (MI) - ITALIA
Tel: +39 02 952451 - Fax: +39 02 95245238/37

P.Iva/Cod.Fisc.: 08763060152 - Cap. Soc. € 110.000,00 i.v.

 

CERTIFIED QUALITY

Nuclear Laser Medicine srl is certified